T. Rowe Price Associates’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $321K | Buy |
11,856
+1,422
| +14% | +$47.8K | ﹤0.01% | 2655 |
|
|
2025
Q4 | $447K | Buy |
10,434
+1,149
| +12% | +$43.3K | ﹤0.01% | 2448 |
|
|
2025
Q3 | $264K | Buy |
+9,285
| New | +$278K | ﹤0.01% | 2667 |
|
|
2024
Q4 | – | Sell |
-12,414
| Closed | -$201K | – | 3051 |
|
|
2024
Q3 | $201K | Buy |
12,414
+1,110
| +10% | +$13.1K | ﹤0.01% | 2651 |
|
|
2024
Q2 | $93K | Sell |
11,304
-1
| -0% | -$10 | ﹤0.01% | 2769 |
|
|
2024
Q1 | $168K | Buy |
11,305
+912
| +9% | +$12.3K | ﹤0.01% | 2670 |
|
|
2023
Q4 | $151K | Buy |
10,393
+368
| +4% | +$3.76K | ﹤0.01% | 2627 |
|
|
2023
Q3 | $109K | Buy |
10,025
+138
| +1% | +$1.66K | ﹤0.01% | 2651 |
|
|
2023
Q2 | $128K | Sell |
9,887
-1,395
| -12% | -$18.9K | ﹤0.01% | 2643 |
|
|
2023
Q1 | $149K | Buy |
11,282
+411
| +4% | +$6.53K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $163K | Hold |
10,871
| – | – | ﹤0.01% | 2592 |
|
|
2022
Q3 | $129K | Sell |
10,871
-5,959
| -35% | -$80.6K | ﹤0.01% | 2664 |
|
|
2022
Q2 | $190K | Buy |
16,830
+8,520
| +103% | +$171K | ﹤0.01% | 2618 |
|
|
2022
Q1 | $248K | Buy |
8,310
+2,864
| +53% | +$77.5K | ﹤0.01% | 2631 |
|
|
2021
Q4 | $144K | Sell |
5,446
-350
| -6% | -$10.6K | ﹤0.01% | 2817 |
|
|
2021
Q3 | $210K | Buy |
5,796
+111
| +2% | +$4.37K | ﹤0.01% | 2706 |
|
|
2021
Q2 | $247K | Buy |
5,685
+1,290
| +29% | +$48.7K | ﹤0.01% | 2650 |
|
|
2021
Q1 | $150K | Buy |
4,395
+3,234
| +279% | +$128K | ﹤0.01% | 2739 |
|
|
2020
Q4 | $41K | Sell |
1,161
-90
| -7% | -$2.61K | ﹤0.01% | 2654 |
|
|
2020
Q3 | $30K | Hold |
1,251
| – | – | ﹤0.01% | 2568 |
|
|
2020
Q2 | $23K | Sell |
1,251
-392,736
| -100% | -$7.07M | ﹤0.01% | 2484 |
|
|
2020
Q1 | $6.15M | Buy |
393,987
+11,346
| +3% | +$242K | ﹤0.01% | 1303 |
|
|
2019
Q4 | $8.19M | Buy |
382,641
+1,171
| +0.3% | +$24.1K | ﹤0.01% | 1342 |
|
|
2019
Q3 | $7.13M | Sell |
381,470
-128,153
| -25% | -$2.65M | ﹤0.01% | 1334 |
|
|
2019
Q2 | $13.3M | Buy |
509,623
+40
| +0% | +$903 | ﹤0.01% | 1271 |
|
|
2019
Q1 | $13.1M | Buy |
509,583
+53,321
| +12% | +$1.22M | ﹤0.01% | 1279 |
|
|
2018
Q4 | $10.5M | Buy |
456,262
+1,550
| +0.3% | +$43.7K | ﹤0.01% | 1300 |
|
|
2018
Q3 | $14.6M | Buy |
454,712
+100,627
| +28% | +$3.02M | ﹤0.01% | 1307 |
|
|
2018
Q2 | $10M | Buy |
354,085
+85,509
| +32% | +$3.04M | ﹤0.01% | 1343 |
|
|
2018
Q1 | $9.51M | Buy |
268,576
+181
| +0.1% | +$7.25K | ﹤0.01% | 1343 |
|
|
2017
Q4 | $10.4M | Sell |
268,395
-9,720
| -3% | -$370K | ﹤0.01% | 1334 |
|
|
2017
Q3 | $7.06M | Buy |
278,115
+42,055
| +18% | +$1.02M | ﹤0.01% | 1394 |
|
|
2017
Q2 | $6.44M | Sell |
236,060
-39,323
| -14% | -$1.08M | ﹤0.01% | 1383 |
|
|
2017
Q1 | $9.12M | Buy |
275,383
+103,980
| +61% | +$2.65M | ﹤0.01% | 1350 |
|
|
2016
Q4 | $4.08M | Buy |
171,403
+73,966
| +76% | +$2.12M | ﹤0.01% | 1443 |
|
|
2016
Q3 | $3.58M | Buy |
97,437
+76,401
| +363% | +$2.19M | ﹤0.01% | 1458 |
|
|
2016
Q2 | $469K | Hold |
21,036
| – | – | ﹤0.01% | 1988 |
|
|
2016
Q1 | $438K | Sell |
21,036
-129
| -0.6% | -$3.18K | ﹤0.01% | 2026 |
|
|
2015
Q4 | $641K | Sell |
21,165
-1,080
| -5% | -$32.7K | ﹤0.01% | 1852 |
|
|
2015
Q3 | $549K | Buy |
22,245
+25
| +0.1% | +$746 | ﹤0.01% | 1911 |
|
|
2015
Q2 | $713K | Hold |
22,220
| – | – | ﹤0.01% | 1866 |
|
|
2015
Q1 | $793K | Buy |
22,220
+500
| +2% | +$13.7K | ﹤0.01% | 1805 |
|
|
2014
Q4 | $493K | Hold |
21,720
| – | – | ﹤0.01% | 1962 |
|
|
2014
Q3 | $421K | Hold |
21,720
| – | – | ﹤0.01% | 2010 |
|
|
2014
Q2 | $788K | Buy |
21,720
+5,928
| +38% | +$202K | ﹤0.01% | 1788 |
|
|
2014
Q1 | $613K | Buy |
+15,792
| New | +$563K | ﹤0.01% | 1843 |
|
|
2013
Q4 | – | Sell |
-461,180
| Closed | -$16.5M | – | 2508 |
|
|
2013
Q3 | $16.5M | Sell |
461,180
-35,280
| -7% | -$1.29M | ﹤0.01% | 1140 |
|
|
2013
Q2 | $16.6M | Buy |
+496,460
| New | +$22.5M | ﹤0.01% | 1118 |
|
Other funds holding RIGL
AC
VCM
